We are live on ! Find out more
Emerald Advisers

Emerald Advisers Portfolio holdings

AUM $4.25B Turnover 24.28%
1-Year Est. Return 141.71%
This Fund
S&P 500
This Quarter Est. Return
+50.94%
1 Year Est. Return
+141.71%
3 Year Est. Return
+486.97%
5 Year Est. Return
+675.33%
10 Year Est. Return
+5,134.29%
AUM
$4.25B
AUM Growth
+$1.09B
Cap. Flow
-$109M
Cap. Flow %
-2.57%
Top 10 Hldgs %
17.4%
Holding
276
New
28
Increased
80
Reduced
84
Closed
39
Avg Time Held
2.5 years
Top 10 Avg Time Held
0.1 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
LGN icon
Legence Corp
LGN
+$53.3M
2
SXT icon
Sensient Technologies
SXT
+$43.9M
3
IDCC icon
InterDigital
IDCC
+$35.5M
4
ACLS icon
Axcelis
ACLS
+$34.7M
5
TEX icon
Terex
TEX
+$34.1M

Sector Composition

Rank Sector Weight
1 Technology 27.23%
2 Industrials 23.28%
3 Healthcare 21.93%
4 Financials 9.1%
5 Consumer Discretionary 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MP icon
151
MP Materials
MP
$6.67B
$1M 0.02%
17,883
-163
-0.9% -$9.9K
2025 Q3
3 quarters
HEI icon
152
HEICO Corp
HEI
$42.7B
$993K 0.02%
2,787
– –
2024 Q1
9 quarters
MDB icon
153
MongoDB
MDB
$31B
$978K 0.02%
2,911
-612
-17% -$184K
2020 Q2
24 quarters
P icon
154
Everpure Inc
P
$42.4B
$978K 0.02%
12,409
+2,615
+27% +$192K
2018 Q1
33 quarters
GBFH icon
155
GBank Financial Holdings
GBFH
$252M
$886K 0.02%
29,227
– –
2025 Q2
4 quarters
TEVA icon
156
Teva Pharmaceutical Industries Limited
TEVA
$46.3B
$832K 0.02%
24,548
-9,741
-28% -$324K
2023 Q3
11 quarters
TER icon
157
Teradyne
TER
$48.2B
$808K 0.02%
+1,669
New +$630K
2026 Q2
0 quarters
UTHR icon
158
United Therapeutics
UTHR
$25.2B
$796K 0.02%
1,469
+400
+37% +$225K
2024 Q3
7 quarters
CAVA icon
159
CAVA Group
CAVA
$6.06B
$767K 0.02%
9,774
+1,881
+24% +$158K
2025 Q2
4 quarters
INDI icon
160
indie Semiconductor
INDI
$369M
$767K 0.02%
170,762
+3,682
+2% +$14.7K
2023 Q1
13 quarters
TDY icon
161
Teledyne Technologies
TDY
$29.8B
$748K 0.02%
1,121
– –
2024 Q2
8 quarters
V icon
162
Visa
V
$762B
$719K 0.02%
2,095
-28
-1% -$8.99K
2017 Q4
34 quarters
MPWR icon
163
Monolithic Power Systems
MPWR
$56.2B
$711K 0.02%
514
-760
-60% -$1.14M
2021 Q2
20 quarters
NFLX icon
164
Netflix
NFLX
$271B
$696K 0.02%
9,744
+24
+0.2% +$2.11K
2023 Q4
10 quarters
COST icon
165
Costco
COST
$448B
$674K 0.02%
721
-10
-1% -$10K
2021 Q4
18 quarters
HOOD icon
166
Robinhood
HOOD
$83.1B
$667K 0.02%
6,647
-3,176
-32% -$266K
2024 Q4
6 quarters
OFRM icon
167
Once Upon a Farm PBC
OFRM
$679M
$664K 0.02%
32,401
-313,688
-91% -$5.14M
2026 Q1
1 quarter
VST icon
168
Vistra
VST
$47.2B
$655K 0.02%
4,132
– –
2024 Q3
7 quarters
BROS icon
169
Dutch Bros
BROS
$5.86B
$649K 0.02%
9,033
– –
2025 Q2
4 quarters
FIVE icon
170
Five Below
FIVE
$12.8B
$633K 0.01%
3,518
-79,833
-96% -$17.2M
2025 Q1
5 quarters
H icon
171
Hyatt Hotels
H
$16.5B
$618K 0.01%
3,189
– –
2021 Q1
21 quarters
LHX icon
172
L3Harris
LHX
$47.9B
$593K 0.01%
2,042
– –
2019 Q2
28 quarters
NOW icon
173
ServiceNow
NOW
$163B
$592K 0.01%
5,965
-69
-1% -$6.83K
2025 Q1
5 quarters
PNFP icon
174
Pinnacle Financial Partners Inc
PNFP
$15.3B
$592K 0.01%
5,870
+1,373
+31% +$132K
2023 Q3
11 quarters
BWMN icon
175
Bowman Consulting
BWMN
$711M
$590K 0.01%
20,198
+6,574
+48% +$207K
2024 Q2
8 quarters

Similar funds

Emerald Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Emerald Advisers held 276 positions worth $4.25B, up 34% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Emerald Advisers's Q2 2026 filing shows 28 new, 80 increased, 84 reduced and 39 closed positions. Its largest new stake was Legence Corp: 653,788 shares worth $55.7M. The largest sale was Bloom Energy, an estimated $137M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

  • Emerald Advisers's largest Q2 2026 buy was Legence Corp: 653,788 shares worth $55.7M.
  • Emerald Advisers added most to InterDigital in Q2 2026, an estimated $35.5M increase.
  • Emerald Advisers's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $137M.
  • Emerald Advisers fully exited BridgeBio Pharma in Q2 2026, selling an estimated $38.3M.
  • Emerald Advisers's ten largest holdings make up 17% of its $4.25B portfolio in Q2 2026.
  • Emerald Advisers opened 28 new positions and closed 39 in Q2 2026.
  • Emerald Advisers's portfolio value rose 34% quarter-over-quarter to $4.25B.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.